PREDICTIVE VALUE OF CA-125 FOR OVARIAN-CARCINOMA IN PATIENTS PRESENTING WITH PELVIC MASSES
- 1 December 1987
- journal article
- research article
- Vol. 70 (6) , 930-932
Abstract
Between November 1984 and May 1986, 56 patients presenting with a pelvic mass to the Gynecologic Oncology Service of McMaster University and the Hamilton Regional Oncology Center underwent laparotomy for possible ovarian cancer. All patients had blood drawn for CA 125 three days before operation. Levels above 35 U/mL were considered positive; CA 125 had a positive predictive value of 60%. False positives occurred in patients with nongynecologic malignancies and with benign gynecologic conditions. On the other hand, CA 125 had a negative predictive value of 100%, suggesting that this test may be useful in identifying those patients with pelvic masses at higher risk for malignancy, who may require transfer for surgery at a tertiary care center.This publication has 5 references indexed in Scilit:
- PREOPERATIVE EVALUATION OF SERUM CA-125 LEVELS IN PATIENTS WITH PRIMARY EPITHELIAL OVARIAN-CANCER1986
- Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinomaGynecologic Oncology, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems.Clinical Chemistry, 1981